Lantern Pharma Inc.LTRNNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank0
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$-17.81M
↓ 93% vs avg
Percentile
P0
Near historical low
Streak
6 yr
Consecutive declineContracting
Average
$-9.22M
Historical baseline
PeriodValueYoY Change
2024$-17.81M-24.2%
2023$-14.35M-12.4%
2022$-12.77M-20.5%
2021$-10.59M-87.4%
2020$-5.65M-165.6%
2019$-2.13M-67.4%
2018$-1.27M-